2009.10.29 Weekly Broadcast Email
The following updates were made to the website for the week of October 26, 2009.
________________________________________
91105: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Appendices 12, 13 and 14, Cognitive Testing Booklets, were updated in the most recent amendment (8). The “Old Booklets” from a previous amendment will remain posted in CCRBIS for 90 days after amendment 8 was released. This will allow sites time to have the appendices approved by their IRBs if required.
________________________________________
New Site: Iowa Oncology Research Association
Please join me in welcoming our newest CCOP, Iowa Oncology Research Association, to the WFU CCOP Research Base. We look forward to working with IORA.
________________________________________
Reminder:
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 9 minority accrual slots open for patient accruals. We would like to see this study close by the end of the year, so if you have patients that may be eligible for this study, please try and get them registered by then.
Thank you,
Lisa Hawkins
Wake Forest University Baptist Medical Center
Department of Radiation Oncology
Research Base Protocol Information Office
2000 West First Street, Suite 401
Winston-Salem, NC 27104
Phone: 336-716-0891
Pager: 336-716-2440, ID number 1689
Fax: 336-716-6275